These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9520115)

  • 1. Lp(a) lipoprotein level predicts survival and major coronary events in the Scandinavian Simvastatin Survival Study.
    Berg K; Dahlén G; Christophersen B; Cook T; Kjekshus J; Pedersen T
    Clin Genet; 1997 Nov; 52(5):254-61. PubMed ID: 9520115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1994 Nov; 344(8934):1383-9. PubMed ID: 7968073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S).
    Miettinen TA; Pyörälä K; Olsson AG; Musliner TA; Cook TJ; Faergeman O; Berg K; Pedersen T; Kjekshus J
    Circulation; 1997 Dec; 96(12):4211-8. PubMed ID: 9416884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering.
    Pedersen TR; Wilhelmsen L; Faergeman O; Strandberg TE; Thorgeirsson G; Troedsson L; Kristianson J; Berg K; Cook TJ; Haghfelt T; Kjekshus J; Miettinen T; Olsson AG; Pyörälä K; Wedel H
    Am J Cardiol; 2000 Aug; 86(3):257-62. PubMed ID: 10922429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery disease: the Scandinavian Simvastatin Survival Study experience.
    Pedersen TR
    Am J Cardiol; 1998 Nov; 82(10B):53T-56T. PubMed ID: 9860376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing the risk of coronary events: evidence from the Scandinavian Simvastatin Survival Study (4S).
    Kjekshus J; Pedersen TR
    Am J Cardiol; 1995 Sep; 76(9):64C-68C. PubMed ID: 7572690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study.
    Haffner SM; Alexander CM; Cook TJ; Boccuzzi SJ; Musliner TA; Pedersen TR; Kjekshus J; Pyörälä K
    Arch Intern Med; 1999 Dec 13-27; 159(22):2661-7. PubMed ID: 10597756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
    Lancet; 1995 May; 345(8960):1274-5. PubMed ID: 7746058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S).
    Pyŏrälä K; Pedersen TR; Kjekshus J; Faergeman O; Olsson AG; Thorgeirsson G
    Diabetes Care; 1997 Apr; 20(4):614-20. PubMed ID: 9096989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Carnitine/Simvastatin Reduces Lipoprotein (a) Levels Compared with Simvastatin Monotherapy: A Randomized Double-Blind Placebo-Controlled Study.
    Florentin M; Elisaf MS; Rizos CV; Nikolaou V; Bilianou E; Pitsavos C; Liberopoulos EN
    Lipids; 2017 Jan; 52(1):1-9. PubMed ID: 27914033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).
    Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J;
    Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.
    Solfrizzi V; Capurso C; Colacicco AM; D'Introno A; Fontana C; Capurso SA; Torres F; Gadaleta AM; Koverech A; Capurso A; Panza F
    Atherosclerosis; 2006 Oct; 188(2):455-61. PubMed ID: 16384561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin.
    Slunga L; Johnson O; Dahlén GH
    Eur J Clin Pharmacol; 1992; 43(4):369-73. PubMed ID: 1451715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.
    Schaefer EJ; Lamon-Fava S; Jenner JL; McNamara JR; Ordovas JM; Davis CE; Abolafia JM; Lippel K; Levy RI
    JAMA; 1994 Apr; 271(13):999-1003. PubMed ID: 8139085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).
    Pyörälä K; Ballantyne CM; Gumbiner B; Lee MW; Shah A; Davies MJ; Mitchel YB; Pedersen TR; Kjekshus J;
    Diabetes Care; 2004 Jul; 27(7):1735-40. PubMed ID: 15220255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for a major coronary event after myocardial infarction in the Scandinavian Simvastatin Survival Study (4S). Impact of predicted risk on the benefit of cholesterol-lowering treatment.
    Wilhelmsen L; Pyörälä K; Wedel H; Cook T; Pedersen T; Kjekshus J
    Eur Heart J; 2001 Jul; 22(13):1119-27. PubMed ID: 11428852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia.
    van Wissen S; Smilde TJ; Trip MD; de Boo T; Kastelein JJ; Stalenhoef AF
    Heart; 2003 Aug; 89(8):893-6. PubMed ID: 12860867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin compared to fluvastatin in the reduction of serum lipids and apolipoproteins in patients with ischaemic heart disease and moderate hypercholesterolaemia.
    Sigurdsson G; Haraldsdottir SO; Melberg TH; Tikkanen MJ; Miettinen TE; Kristianson KJ
    Acta Cardiol; 1998; 53(1):7-14. PubMed ID: 9638964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.